Circulating tumour cells and cell-free DNA as tools for managing breast cancer.
about
Cell-free circulating tumor DNA in cancercfDNA analysis from blood in melanomaMolecular Imaging of Biomarkers in Breast CancerRevealing the Complexity of Breast Cancer by Next Generation SequencingEpigenetic mechanisms involved in melanoma pathogenesis and chemoresistanceExtracellular vesicles as a platform for 'liquid biopsy' in glioblastoma patientsMolecular imaging of breast cancer: present and future directionsLiquid biopsies: genotyping circulating tumor DNAGenomic profiling of breast cancersSignatures of breast cancer metastasis at a glanceThe possibility of clinical sequencing in the management of cancerSystemic treatment approaches in her2-negative advanced breast cancer-guidance on the guidelinesOrganoid development in cancer genome discoveryTranslating neoadjuvant therapy into survival benefits: one size does not fit all.Predictive biomarkers for triple negative breast cancer treated with platinum-based chemotherapy.Circulating Tumor DNA as Biomarkers for Cancer Detection.Clinical validation of an ultra high-throughput spiral microfluidics for the detection and enrichment of viable circulating tumor cells.BRAF V600E mutations in urine and plasma cell-free DNA from patients with Erdheim-Chester diseaseClinical significance of phenotyping and karyotyping of circulating tumor cells in patients with advanced gastric cancerBone marrow minimal residual disease was an early response marker and a consistent independent predictor of survival after anti-GD2 immunotherapy.Multiplexed detection of serological cancer markers with plasmon-enhanced Raman spectro-immunoassay.Genetic profiling of tumours using both circulating free DNA and circulating tumour cells isolated from the same preserved whole blood sample.Efficient Capture and Isolation of Tumor-Related Circulating Cell-Free DNA from Cancer Patients Using Electroactive Conducting Polymer Nanowire PlatformsHeterogeneity and clinical significance of ESR1 mutations in ER-positive metastatic breast cancer patients receiving fulvestrant.Comprehensive mutation profiling by next-generation sequencing of effusion fluids from patients with high-grade serous ovarian carcinoma.Analysis of tumor template from multiple compartments in a blood sample provides complementary access to peripheral tumor biomarkersPilot studies for personalized cancer medicine: focusing on the patient for treatment selection.Copy number variations in urine cell free DNA as biomarkers in advanced prostate cancer.Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer.Aneuploidy of chromosome 8 in circulating tumor cells correlates with prognosis in patients with advanced gastric cancer.Concordance between genomic alterations assessed by next-generation sequencing in tumor tissue or circulating cell-free DNA.Latest biopsy approach for suspected metastases in patients with breast cancer.Molecular analysis of circulating tumour cells-biology and biomarkers.Tumor heterogeneity in the clinic: is it a real problem?Brain metastasis: new opportunities to tackle therapeutic resistance.The intra-tumor heterogeneity of cell signaling factors in breast cancer: p4E-BP1 and peIF4E are diffusely expressed and are real potential targets.Capturing intra-tumor genetic heterogeneity by de novo mutation profiling of circulating cell-free tumor DNA: a proof-of-principle.Clinical management of breast cancer heterogeneity.Evaluation of targeted therapies in advanced breast cancer: the need for large-scale molecular screening and transformative clinical trial designs.Cell-free circulating tumour DNA as a liquid biopsy in breast cancer.
P2860
Q26750899-9BC8813A-038C-44F7-88C7-082F81DB143FQ26772199-5983E525-6ACB-43D4-9AF3-B5D1ED4BCB4FQ26772870-6766CA72-626E-43D7-BD46-86A560E824B7Q26777395-F98D63BB-D341-40D1-9B79-A33AAEA29682Q26778761-883FC78A-6009-4A8E-B485-50185526FDF4Q26861832-2511EDEA-B433-4552-9BE3-A17E7FFCD922Q26999488-6719062E-32CD-452E-A39C-70AC970FA95BQ27010159-D8B4CE59-C126-4C9A-A00F-7DC4A12E5C56Q27013013-95E545A4-FFAC-4549-A211-67EF1EAF329CQ28071451-FA2A3CAB-F4D6-4B9C-A756-0768FCF28084Q28072144-24069BFC-538C-4F74-9F00-131B4A23F68DQ28080469-393070CE-4FA6-494E-8F6D-2C73246A7B33Q28083032-DCC22BA7-59A7-4216-B991-A53C6FED98D2Q30251738-6AC25EB3-2839-4A78-8DB9-A0FE7B701965Q33441772-1F8003E0-04C0-48B2-8226-33EEC181D632Q33632125-0FE9CEA2-C30A-415A-A50A-38984E56266FQ33856619-290C4058-7597-4C18-A4DA-96D45C27BD57Q33976971-19E62459-F90E-4BB0-BE16-4F2A3E04F609Q34334315-01B1B677-50DA-4C4C-92CE-616E62B1ADB4Q35102499-BDADE23E-FAFD-45E2-971B-E74857495003Q35787480-00E41B54-5FDB-4770-BA34-1EF33EDB52EAQ36807241-4D24CB5C-7A0B-47C9-BBD9-6D39DE9AE0FFQ36882961-393D36B5-D70D-435E-A60B-DF3B0A1D19A0Q36907216-A6E4A78E-E019-4ED3-88B5-4F7E918ED8B0Q37193365-048C656D-D02C-4359-9A51-4F1BF1A5C5DFQ37295773-261746AE-696E-4CE8-B150-7856CB3A4B38Q37301452-78B47AF8-D3CD-4817-BC6A-E772B414E5DAQ37392579-5B65F0C8-56EB-4049-AE46-6BB00DCC569AQ37533025-958408EE-D775-4E4A-B24E-6B53E2F2263BQ37592228-54644741-C395-47E7-8CA4-3834EB45ECD5Q37662237-67DAAAE6-927B-4FCD-AF52-6D9FAAC3297BQ38154494-EB22A811-11EF-446A-B32C-9C5018FEA111Q38180320-CD6B51F9-A772-41D6-B0EA-FCCC78B84F2DQ38192631-DAFBB076-0D5B-43F8-BC9B-DDFB799E417EQ38222247-43A486A2-E48E-4B39-B24A-F10200F2DBCDQ38233765-6E17245F-86ED-4B2C-B7C8-FD9251A0F3FBQ38390966-CC5A5E22-76A1-4BD1-80FC-85574772EB93Q38431284-66A5E869-265B-42DB-BB29-CC4F3085C0B5Q38539671-C83E36C9-C436-4F50-A0B1-595723DF19B7Q38699764-8FBE9E0E-AF1F-4BFC-943F-CE9CB84D4C10
P2860
Circulating tumour cells and cell-free DNA as tools for managing breast cancer.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Circulating tumour cells and cell-free DNA as tools for managing breast cancer.
@en
type
label
Circulating tumour cells and cell-free DNA as tools for managing breast cancer.
@en
prefLabel
Circulating tumour cells and cell-free DNA as tools for managing breast cancer.
@en
P2093
P2860
P50
P1476
Circulating tumour cells and cell-free DNA as tools for managing breast cancer.
@en
P2093
Ana Vivancos
Javier Cortes
Leticia De Mattos-Arruda
Libero Santarpia
P2860
P2888
P304
P356
10.1038/NRCLINONC.2013.80
P407
P577
2013-05-28T00:00:00Z
P6179
1035963907